Humanized Monoclonal Antibody May Be Effective, Safe in Asthma Patients – Medscape

Humanized Monoclonal Antibody May Be Effective, Safe in Asthma Patients
Medscape
January 11, 2011 — Add-on therapy with subcutaneous omalizumab is safe and effective in patients with moderate to severe allergic asthma, according to the

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.